TABLE 2.
Patient # | AST (U/L) | ALT (U/L) | ALP (U/L) | Total Bilirubin (mg/dL) | Direct Bilirubin (mg/dL) | GGT (U/L) | Classical AIH Markers |
||
---|---|---|---|---|---|---|---|---|---|
ANA | ASMA | Anti-LKM | |||||||
1 | 241 | 324 | 199 | 0.4 | N/A | 35 | − | + | + |
2 | 88 | 134 | 230 | 0.5 | 0.5 | 42 | − | N/A | − |
3 | 930 | 1,992 | 164 | 2.3 | 0.7 | 525 | − | − | − |
4 | 93 | 105 | N/A | N/A | N/A | 525 | N/A | − | − |
5 | 2,603 | 1,587 | 618 | 7.2 | 4.3 | N/A | N/A | − | +* |
6 | 98 | 75 | 133 | 0.41 | N/A | 81 | − | − | − |
Weak positive at titer 1:20.
Abbreviation: N/A, not available.